965 results on '"Thorens, Bernard"'
Search Results
2. GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion
3. Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia
4. Correction: Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes
5. Correction: Cold-induced dishabituation in rodents exposed to recurrent hypoglycaemia
6. A multiorgan map of metabolic, signaling, and inflammatory pathways that coordinately control fasting glycemia in mice
7. The glucose transporter 2 regulates CD8+ T cell function via environment sensing
8. Identification of biomarkers for glycaemic deterioration in type 2 diabetes
9. Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes
10. Correction to: Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia
11. Oral metformin transiently lowers post-prandial glucose response by reducing the apical expression of sodium-glucose co-transporter 1 in enterocytes
12. SAT-231 GL0034 (Utreglutide), a long acting, glucagon-like peptide-1 receptor agonist, improves body weight loss, lipid and liver injury markers in individuals with obesity: A phase 1 multiple ascending dose study
13. Hypothalamic Irak4 is a genetically controlled regulator of hypoglycemia-induced glucagon secretion
14. GLUT2 expression by glial fibrillary acidic protein-positive tanycytes is required for promoting feeding-response to fasting
15. Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function
16. Lipid biosynthesis enzyme Agpat5 in AgRP-neurons is required for insulin-induced hypoglycemia sensing and glucagon secretion
17. Plasma triacylglycerols are biomarkers of β-cell function in mice and humans
18. Neuronal glucose sensing mechanisms and circuits in the control of insulin and glucagon secretion
19. Ablation of glucokinase-expressing tanycytes impacts energy balance and increases adiposity in mice
20. Glucokinase neurons of the paraventricular nucleus of the thalamus sense glucose and decrease food consumption
21. Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study
22. Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories towards type 2 diabetes
23. Cold-induced dishabituation in rodents exposed to recurrent hypoglycaemia
24. Building the Glucagon-Like Peptide-1 Receptor Brick by Brick: Revisiting a 1993 Diabetes Classic by Thorens et al.
25. A genetic screen identifies Crat as a regulator of pancreatic beta-cell insulin secretion
26. Klf6 protects β-cells against insulin resistance-induced dedifferentiation
27. GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion
28. Use of preclinical models to identify markers of type 2 diabetes susceptibility and novel regulators of insulin secretion – A step towards precision medicine
29. Laser capture microdissection of human pancreatic islets reveals novel eQTLs associated with type 2 diabetes
30. Profound Perturbation of the Metabolome in Obesity Is Associated with Health Risk
31. Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia
32. Hyperglycemia increases SCO-spondin and Wnt5a secretion into the cerebrospinal fluid to regulate ependymal cell beating and glucose sensing
33. SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney
34. Tmem117 in AVP neurons regulates the counterregulatory response to hypoglycemia
35. GL0034 (Utreglutide), a novel, long acting, glucagon-like peptide 1 receptor agonist (GLP-1 RA), results of a phase 1 study in healthy individuals
36. Gene expression signature predicts rate of type 1 diabetes progression
37. Allogeneic β-Islet Cells Correct Diabetes and Resist Immune Rejection
38. Molecular phenotyping of multiple mouse strains under metabolic challenge uncovers a role for Elovl2 in glucose-induced insulin secretion
39. Normal Kinetics of Intestinal Glucose Absorption in the Absence of GLUT2: Evidence for a Transport Pathway Requiring Glucose Phosphorylation and Transfer into the Endoplasmic Reticulum
40. Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes
41. Fostering improved human islet research: a European perspective
42. Normal Hepatic Glucose Production in the Absence of GLUT2 Reveals an Alternative Pathway for Glucose Release from Hepatocytes
43. Protective role of the ELOVL2/docosahexaenoic acid axis in glucolipotoxicity-induced apoptosis in rodent beta cells and human islets
44. Glucagon receptor family in GtoPdb v.2023.1
45. A caveolin-1 dependent glucose-6-phosphatase trafficking contributes to hepatic glucose production
46. Insulin Secretion is Regulated by the Glucose-Dependent Production of Islet β Cell Macrophage Migration Inhibitory Factor
47. Assessing the Content Validity, Acceptability, and Feasibility of the Hypo-METRICS App:Survey and Interview Study
48. The Drosophila TNF Eiger Is an Adipokine that Acts on Insulin-Producing Cells to Mediate Nutrient Response
49. Glucose transporter 2 mediates the hypoglycemia-induced increase in cerebral blood flow
50. GLUT2-Expressing Neurons as Glucose Sensors in the Brain: Electrophysiological Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.